- Home
- UCAR vs INKT Comparison
UCAR vs INKT Comparison
Compare UCAR & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCAR
- INKT
- Stock Information
- Founded
- UCAR 2013
- INKT 2017
- Country
- UCAR China
- INKT United States
- Employees
- UCAR N/A
- INKT N/A
- Industry
- UCAR Retail-Auto Dealers and Gas Stations
- INKT Medicinal Chemicals and Botanical Products
- Sector
- UCAR Consumer Discretionary
- INKT Health Care
- Exchange
- UCAR Nasdaq
- INKT Nasdaq
- Market Cap
- UCAR 24.1M
- INKT 28.5M
- IPO Year
- UCAR 2023
- INKT 2021
- Fundamental
- Price
- UCAR $6.60
- INKT $0.49
- Analyst Decision
- UCAR
- INKT Strong Buy
- Analyst Count
- UCAR 0
- INKT 2
- Target Price
- UCAR N/A
- INKT $6.50
- AVG Volume (30 Days)
- UCAR 24.6K
- INKT 53.3K
- Earning Date
- UCAR 10-08-2024
- INKT 11-14-2024
- Dividend Yield
- UCAR N/A
- INKT N/A
- EPS Growth
- UCAR N/A
- INKT N/A
- EPS
- UCAR N/A
- INKT N/A
- Revenue
- UCAR $4,273,899.00
- INKT N/A
- Revenue This Year
- UCAR N/A
- INKT N/A
- Revenue Next Year
- UCAR N/A
- INKT N/A
- P/E Ratio
- UCAR N/A
- INKT N/A
- Revenue Growth
- UCAR 473.55
- INKT N/A
- 52 Week Low
- UCAR $4.21
- INKT $0.46
- 52 Week High
- UCAR $23.00
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- UCAR 46.24
- INKT 27.61
- Support Level
- UCAR $6.35
- INKT $0.46
- Resistance Level
- UCAR $7.79
- INKT $0.67
- Average True Range (ATR)
- UCAR 0.49
- INKT 0.06
- MACD
- UCAR -0.03
- INKT -0.02
- Stochastic Oscillator
- UCAR 19.05
- INKT 9.83
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufactory and sales; battery swapping services and sourcing services. The company as a broker engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.